As for industries, for speculative purchases, yes BIOs are apparently now hot, though I know nothing of this sector to comment.
Really though I'd say that if you are in the money making business rather than speculative future projections then you should be OK.
IFE/TRF just have to go from explorer to producer and gain financial inputs to be OK.
Will approved finance cause a re-rating? Possibly, but actual shipping (at decent prices, and seeing cash hitting the books) will be the real trigger.
As for finance causing a mini-rerating. Just ask yourself, would you be prepared to purchase more stock once finance was approved? If you do and so do the masses, and sellers dry out, then by implication the SP will rise. A rising SP will give more confidence to others, and in turn may cause it to rise again. This will balance out with sellers, seeing an exit price they are happy with.
Ultimately short term SP will be unpredictable. Long term (this time next year), assuming finance comes off, and shipping at profit occurs, IFE and therefore TRF SP must be higher. If profit hits the books and SP does rise, a dividend in the way BCI have done, when they went form explorer to producer can further bring attention to the stock, and pay loyal shareholders sensible returns....
Just musing ... and waiting ... perpetual waiting..... surely this must be the year.
Current concern on TRF sp would be how much cash at hand before IFE comes good, TRF would need some exploration success and rise in SP before any future CR in my opinion.
Good luck to all.
TRF Price at posting:
10.0¢ Sentiment: Buy Disclosure: Held
